Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
IRVINE, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Elizabeth Yeu, M.D. to its Board of Directors. Dr. Yeu will continue to serve as Tarsus’ Chief Medical Advisor. As part of her Board appointment, she will join the Science and Technology Committee, which provides strategic direction on external and internal innovation and pipeline opportunities. With over 20 years of broad eye care experience, Dr. Yeu brings proven clinical leadership to the Tarsus Board.
- With over 20 years of broad eye care experience, Dr. Yeu brings proven clinical leadership to the Tarsus Board.
- Dr. Yeu is a prominent and well-respected thought leader and clinician and has a deep understanding of the unmet needs in eye care.
- Dr. Yeu currently serves on the Boards of Directors of STAAR Surgical, Ocular Science, and the Virginia Eye Foundation.
- Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care.